These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15763782)

  • 1. An assessment of the Down syndrome antenatal screening policies of East and West Gloucestershire between 1993 and 1999.
    Dixon J; Pillai M; Mahendran D; Brooks M
    J Obstet Gynaecol; 2004 Oct; 24(7):760-4. PubMed ID: 15763782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal screening for Down's syndrome with use of maternal serum markers.
    Haddow JE; Palomaki GE; Knight GJ; Williams J; Pulkkinen A; Canick JA; Saller DN; Bowers GB
    N Engl J Med; 1992 Aug; 327(9):588-93. PubMed ID: 1379344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison and integration of first trimester fetal nuchal translucency and second trimester maternal serum screening for fetal Down syndrome.
    Lam YH; Lee CP; Sin SY; Tang R; Wong HS; Wong SF; Fong DY; Tang MH; Woo HH
    Prenat Diagn; 2002 Aug; 22(8):730-5. PubMed ID: 12210586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.
    Dick PT
    CMAJ; 1996 Feb; 154(4):465-79. PubMed ID: 8630836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience.
    Spencer K; Nicolaides KH
    BJOG; 2003 Mar; 110(3):276-80. PubMed ID: 12628267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evolving national birth prevalence of Down syndrome in Taiwan. A study on the impact of second-trimester maternal serum screening.
    Jou HJ; Kuo YS; Hsu JJ; Shyu MK; Hsieh TT; Hsieh FJ
    Prenat Diagn; 2005 Aug; 25(8):665-70. PubMed ID: 16049991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective assessment of the Hong Kong Hospital Authority universal Down syndrome screening programme.
    Sahota DS; Leung WC; Chan WP; To WW; Lau ET; Leung TY
    Hong Kong Med J; 2013 Apr; 19(2):101-8. PubMed ID: 23535668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal screening for Down syndrome.
    Ogle RF; Chitty LS
    Hosp Med; 1998 Aug; 59(8):632-6. PubMed ID: 9829057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thoughts about screening for Down syndrome].
    Gardó S
    Orv Hetil; 2009 Mar; 150(11):497-501; discussion 501-2. PubMed ID: 19258245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening.
    Haddow JE; Palomaki GE; Knight GJ; Cunningham GC; Lustig LS; Boyd PA
    N Engl J Med; 1994 Apr; 330(16):1114-8. PubMed ID: 7510852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on key techniques and intervention in reducing birth defects].
    Zhu BS; Su J; Lu XH; He J; Zhu S; Jiao CX; Zhang JM; Tang XH; Tao Y; Lin KP; Chen H; Li SY
    Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):658-63. PubMed ID: 22176989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antenatal screening for Down syndrome.
    Wald NJ
    Prog Clin Biol Res; 1995; 393():27-42. PubMed ID: 8545455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.
    Mooney RA; Peterson CJ; French CA; Saller DN; Arvan DA
    Obstet Gynecol; 1994 Aug; 84(2):298-303. PubMed ID: 7518896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down's syndrome: current screening techniques.
    White RS
    South Med J; 1989 Dec; 82(12):1483-6. PubMed ID: 2480649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in the use of second trimester maternal serum screening from 1991 to 2003.
    Benn PA; Fang M; Egan JF
    Genet Med; 2005; 7(5):328-31. PubMed ID: 15915084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SURUSS in perspective.
    Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
    BJOG; 2004 Jun; 111(6):521-31. PubMed ID: 15198778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic counseling, prenatal screening and diagnosis of Down syndrome in the second trimester in women of advanced maternal age: a prospective study.
    Qi QW; Jiang YL; Zhou XY; Liu JT; Yin J; Bian XM
    Chin Med J (Engl); 2013; 126(11):2007-10. PubMed ID: 23769548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol.
    Cheng EY; Luthy DA; Zebelman AM; Williams MA; Lieppman RE; Hickok DE
    Obstet Gynecol; 1993 Jan; 81(1):72-7. PubMed ID: 7677967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal screening for Down syndrome in England and Wales and population-based birth outcomes.
    Smith-Bindman R; Chu P; Bacchetti P; Waters JJ; Mutton D; Alberman E
    Am J Obstet Gynecol; 2003 Oct; 189(4):980-5. PubMed ID: 14586339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The quadruple test for Down syndrome screening in pregnant women of advanced maternal age.
    Kwon JY; Park IY; Kwon SM; Kim CJ; Shin JC
    Arch Gynecol Obstet; 2012 Mar; 285(3):629-33. PubMed ID: 21837420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.